A newly identified COVID-19 variant, dubbed “Cicada” (BA.3.2), is attracting attention due to its significant mutations and emerging presence in multiple countries. While not currently dominant, this strain represents a notable shift in the virus’s evolution, raising questions about immunity and vaccine effectiveness. Here’s a breakdown of what experts are saying about this developing situation.
The Emergence of Cicada
The “Cicada” variant is a descendant of the Omicron strain, which surged globally in 2021. Unlike more recent variants, this lineage remained largely dormant since early 2022 before resurfacing with substantial mutations. This sudden reappearance, noted by evolutionary biologist T. Ryan Gregory, mirrors the insect from which it takes its name — a long period of inactivity followed by a rapid emergence.
Why the Mutations Matter
Cicada has accumulated over 70 substitutions in its spike protein, the part of the virus that binds to human cells. This level of mutation is substantial, distancing it from other circulating Omicron strains. Experts, like Dr. William Schaffner of Vanderbilt University, explain that this divergence may reduce the effectiveness of existing immunity from prior infection or vaccination.
“It’s a more distant cousin to other Omicron variants that are out there. Prior immunity will likely provide some protection, but probably an increased proportion of people are at risk of getting infected.” – Dr. William Schaffner
This doesn’t mean the virus is necessarily more deadly, but it highlights the virus’s continued ability to adapt and evade prior defenses. The rapid evolution of SARS-CoV-2 underscores the importance of ongoing surveillance and adaptation in public health measures.
Current Vaccines and Immunity
Current COVID-19 vaccines are designed to target Omicron, but the substantial mutations in Cicada raise concerns about their effectiveness. Dr. Thomas Russo of the University at Buffalo suggests that while vaccines likely still offer some protection, a larger percentage of the population may now be susceptible to infection.
The CDC has detected Cicada in wastewater samples from 25 U.S. states and in 23 countries worldwide, signaling its spread. This widespread detection, combined with the mutations, suggests a potential for increased transmission.
Symptoms and Precautions
Symptoms associated with Cicada appear consistent with other COVID-19 strains:
- Fever or chills
- Cough
- Shortness of breath
- Sore throat
- Congestion or runny nose
- Loss of taste or smell
- Fatigue
- Muscle aches
- Headache
- Nausea or vomiting
- Diarrhea
If you test positive, experts recommend isolating to prevent further spread. Masks can help reduce transmission when around others. For individuals at high risk of severe illness, antiviral medications may be considered in consultation with a healthcare provider.
The Bigger Picture
COVID-19 remains a significant public health concern. While the initial panic has subsided, the virus continues to evolve, and complacency can be dangerous. Dr. Russo emphasizes that COVID-19 remains more lethal than influenza, and vaccination remains the most effective protection. The emergence of Cicada is a reminder that the pandemic is not over, and vigilance is still required.
The emergence of Cicada underscores the virus’s constant evolution and the need for continued monitoring, vaccine adaptation, and responsible public health measures.
